Funds holding COEPTIS THERAPEUTICS HOLDINGS INC
ISIN US19207A2078 · United States
- Fund holders
- 7
- Of which ETFs
- 0 7 other funds
- Value held
- 4M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 254,749 | 2.9M $ | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 63,199 | 709.1K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 22,069 | 265.6K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 6,214 | 74.8K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 5,317 | 64K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 2,783 | 31.2K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 2,719 | 32.7K $ | 0.00 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 7 | 0 | 357,050 | +2.8 % |
| 2026Q1 | 7 | +1 | 347,271 | +549.3 % |
| 2025Q4 | 6 | +1 | 53,486 | +22.2 % |
| 2025Q3 | 5 | 0 | 43,774 | +23.0 % |
| 2025Q2 | 5 | +4 | 35,583 | +606.3 % |
| 2025Q1 | 1 | 5,038 |
Institutional managers
9 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 53,093 | 596.1K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 26,830 | 301K $ | as of Mar 31, 2026 |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 20,000 | 224.4K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 13,566 | 152.2K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 12,219 | 137.1K $ | as of Mar 31, 2026 |
| Steward Partners Investment Advisory, LLC | 5,000 | 56.1K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 201 | 2.3K $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 100 | 1.1K $ | as of Mar 31, 2026 |
| BARCLAYS PLC | 3 | 34 $ | as of Mar 31, 2026 |
Declared shareholders of COEPTIS THERAPEUTICS HOLDINGS INC
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Capital Management and 1 other | 5.57 % | 346,975 | as of Mar 31, 2026 · SCHEDULE 13G |
| BSG Series CM, LLC | 0.00 % | 0 | as of Apr 30, 2026 · SCHEDULE 13D |
Cite this page
Titelia. "Funds holding COEPTIS THERAPEUTICS HOLDINGS INC". https://titelia.com/en/stocks/coeptis-therapeutics-holdings-inc-US19207A2078